Just-Evotec Biologics and Sandoz Expand their Collaboration for Biosimilar
Shots:
-
Just-Evotec Biologics (Evotec’s biologics segment) & Sandoz have expanded their tech collaboration to develop & manufacture biosimilars. They have been in a multi-year tech collaboration since May 2023
-
Under the agreement, Just-Evotec will get payment for early scientific validation along with additional funding tied to milestones from 2025
-
Through the expanded collaboration, Just-Evotec will provide biosimilar to Sandoz from its new J.POD facility. Sandoz further gets long-term supply guarantees with significant reserved manufacturing capacity
Ref: Sandoz and Just-Evotec Biologics | Image: Sandoz and Just-Evotec Biologics
Related News:- Sandoz Entered into an Agreement with Just - Evotec Biologics to Develop and Manufacture Multiple Biosimilar
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Tags
A passionate content writer with expertise in delivering high-quality and engaging content, Dipanshu is a keen reader and a versatile writer. Dipanshu dedicatedly covers news ranging from biopharma, life sciences, biotech, and MedTech to diagnostics and animal health companies, FDA, EMA, and biosimilar approvals. He can be contacted at connect@pharmashots.com
